Measles vaccine - Bavarian Nordic

Drug Profile

Measles vaccine - Bavarian Nordic

Alternative Names: Measles vaccine MVA mBN85B - Bavarian Nordic; MVA-BN Measles; MVA-mBN85B

Latest Information Update: 21 Aug 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bavarian Nordic
  • Class Measles vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Measles

Most Recent Events

  • 31 Aug 2010 Bavarian Nordic completes a phase II trial in Measles in South Africa (NCT00891007)
  • 31 Mar 2010 Bavarian Nordic completes enrolment in its phase II trial for Measles in South Africa
  • 29 Apr 2008 Immunogenicity data from a phase I trial in healthy volunteers and a preclinical trial in Measles released by Bavarian Nordic
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top